4.8 Article

In vivo base editing rescues cone photoreceptors in a mouse model of early-onset inherited retinal degeneration

Related references

Note: Only part of the references are listed.
Article Engineering, Biomedical

Restoration of visual function in adult mice with an inherited retinal disease via adenine base editing

Susie Suh et al.

Summary: Subretinal viral delivery of an adenine base editor and a single-guide RNA targeting a nonsense mutation in the Rpe65 gene restores near-normal levels of retinal and visual functions in mice.

NATURE BIOMEDICAL ENGINEERING (2021)

Article Multidisciplinary Sciences

In vivo base editing rescues Hutchinson-Gilford progeria syndrome in mice

Luke W. Koblan et al.

Summary: Using adenine base editor (ABE), researchers successfully corrected the pathogenic mutation in fibroblasts from children with Hutchinson-Gilford progeria syndrome, mitigating RNA mis-splicing, reducing progerin levels, and correcting nuclear abnormalities. In vivo base editing with AAV9 encoding ABE in transgenic mice resulted in substantial, durable correction of the mutation, restoration of normal RNA splicing, and improvement of vascular pathology, ultimately extending the lifespan of the mice. These findings demonstrate the potential of in vivo base editing as a treatment for genetic diseases.

NATURE (2021)

Article Multidisciplinary Sciences

In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates

Kiran Musunuru et al.

Summary: This study demonstrates the efficient and precise modification of disease-related genes in living cynomolgus monkeys using CRISPR base editors delivered in vivo via lipid nanoparticles. The results provide proof-of-concept for the potential therapeutic application of CRISPR base editors in making precise single-nucleotide changes in target genes, supporting a 'once-and-done' approach for the treatment of diseases.

NATURE (2021)

Article Biotechnology & Applied Microbiology

In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels

Tanja Rothgangl et al.

Summary: ABEs have been shown to effectively and safely reduce LDL levels in the livers of mice and cynomolgus macaques. Using lipid nanoparticle-based delivery of mRNA encoding an ABE and a sgRNA targeting PCSK9, significant reductions in PCSK9 and LDL levels were achieved in both species. Further research is warranted to explore the potential of ABEs in treating monogenic liver diseases.

NATURE BIOTECHNOLOGY (2021)

Article Multidisciplinary Sciences

Base editing of haematopoietic stem cells rescues sickle cell disease in mice

Gregory A. Newby et al.

Summary: The study demonstrated successful conversion of sickle cell disease allele into a non-pathogenic variant using adenine base editor, with durable therapeutic effects. The edited HSPCs improved physiological parameters and reduced pathological abnormalities in spleens of mice, indicating the potential for long-lasting and effective treatment for SCD.

NATURE (2021)

Article Biotechnology & Applied Microbiology

Long-Term Structural Outcomes of Late-Stage RPE65 Gene Therapy

Kristin L. Gardiner et al.

MOLECULAR THERAPY (2020)

Article Biotechnology & Applied Microbiology

Continuous evolution of SpCas9 variants compatible with non-G PAMs

Shannon M. Miller et al.

NATURE BIOTECHNOLOGY (2020)

Article Multidisciplinary Sciences

Gene regulatory networks controlling vertebrate retinal regeneration

Thanh Hoang et al.

SCIENCE (2020)

Article Biotechnology & Applied Microbiology

Circularly permuted and PAM-modified Cas9 variants broaden the targeting scope of base editors

Tony P. Huang et al.

NATURE BIOTECHNOLOGY (2019)

Article Biotechnology & Applied Microbiology

Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy

Seuk-Min Ryu et al.

NATURE BIOTECHNOLOGY (2018)

Article Biotechnology & Applied Microbiology

Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction

Luke W. Koblan et al.

NATURE BIOTECHNOLOGY (2018)

Article Biochemical Research Methods

Defining CRISPR-Cas9 genome-wide nuclease activities with CIRCLE-seq

Cicera R. Lazzarotto et al.

NATURE PROTOCOLS (2018)

Article Multidisciplinary Sciences

Programmable base editing of A.T to G.C in genomic DNA without DNA cleavage

Nicole M. Gaudelli et al.

NATURE (2017)

Article Biochemical Research Methods

CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR Cas9 nuclease off-targets

Shengdar Q. Tsai et al.

NATURE METHODS (2017)

Article Biochemistry & Molecular Biology

Impact of LCA-Associated E14L LRAT Mutation on Protein Stability and Retinoid Homeostasis

Sylwia Chelstowska et al.

BIOCHEMISTRY (2017)

Article Multidisciplinary Sciences

Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage

Alexis C. Komor et al.

NATURE (2016)

Article Medicine, General & Internal

Long-Term Effect of Gene Therapy on Leber's Congenital Amaurosis

J. W. B. Bainbridge et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Medicine, General & Internal

Improvement and Decline in Vision with Gene Therapy in Childhood Blindness

Samuel G. Jacobson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Ophthalmology

Visual Cone Arrestin 4 Contributes to Visual Function and Cone Health

Janise D. Deming et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)

Article Biochemistry & Molecular Biology

RPE65 gene therapy slows cone loss in Rpe65-deficient dogs

F. M. Mowat et al.

GENE THERAPY (2013)

Article Multidisciplinary Sciences

Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement

Artur V. Cideciyan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Multidisciplinary Sciences

Gene Therapy Regenerates Protein Expression in Cone Photoreceptors in Rpe65R91W1aR91W Mice

Corinne Kostic et al.

PLOS ONE (2011)

Article Biotechnology & Applied Microbiology

Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration

Francesca Simonelli et al.

MOLECULAR THERAPY (2010)

Article Biotechnology & Applied Microbiology

Human RPE65 Gene Therapy for Leber Congenital Amaurosis: Persistence of Early Visual Improvements and Safety at 1 Year

Artur V. Cideciyan et al.

HUMAN GENE THERAPY (2009)

Article Medicine, General & Internal

Safety and efficacy of gene transfer for Leber's congenital amaurosis

Albert M. Maguire et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Medicine, General & Internal

Effect of gene therapy on visual function in Leber's congenital amaurosis

James W. B. Bainbridge et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Review Ophthalmology

Leber congenital amaurosis: Genes, proteins and disease mechanisms

Anneke I. den Hollander et al.

PROGRESS IN RETINAL AND EYE RESEARCH (2008)

Article Multidisciplinary Sciences

Human cone photoreceptor dependence on RPE65 isomerase

Samuel G. Jacobson et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Ophthalmology

Metallothionein, an endogenous antioxidant, protects against retinal neuron damage in mice

Shinsuke Suemori et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)

Article Multidisciplinary Sciences

Making the gradient: Thyroid hormone regulates cone opsin expression in the developing mouse retina

MR Roberts et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Ophthalmology

A critical role of CaBP4 in the cone synapse

T Maeda et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)

Article Multidisciplinary Sciences

Phototransduction in transgenic mice after targeted deletion of the rod transducin α-subunit

PD Calvert et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)